Aktiesnakken — Juli 2010
-
Det er aldrig for tidligt at være munter
-
RA er ca. 15% af rituximabs sales
-
Ja mener omsætningen i 2008 var 800 musd
-
lige over 6mia CHF total rituximab/mabthera
i 2009... ca. 900 CHF på RA -
Det er fede tal i sommer varmen
-
det er vist kun thomas bo larsen der kan se fodbold udenfor i solen
-
så er jeg også tilbe
-
tilbage
-
armstrong vinder for os i trediverne
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind